Stability of extemporaneous rifampicin prepared with X-temp® oral suspension system

Salma Nadirah Md Salim; Mohd Danial Mohd Murshid; Amirah Mohd Gazzali

doi:10.31436/jop.v1i1.42

Authors

Salma Nadirah Md Salim Department of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
Mohd Danial Mohd Murshid Department of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
Amirah Mohd Gazzali Department of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.

DOI:

https://doi.org/10.31436/jop.v1i1.42

Keywords:

extemporaneous, rifampicin, X-temp®, suspension, tuberculosis

Abstract

Introduction: Rifampicin is a first line antituberculosis drug that is commonly used in the treatment of tuberculosis, both in adults and paediatric patients. However, there is a lack of liquid formulation for rifampicin in the market due to the small market size and the physicochemical properties of the drug itself. An innovative new mix called X-Temp® oral suspension system (OSS) has been available in the market as a choice of vehicle for extemporaneous suspension.

Aim: The aim of this study was to prepare rifampicin suspension in the X-Temp® OSS and evaluate its stability following storage at two temperatures – refrigerated (5 °C ± 3 °C) and in a stability chamber (30 °C ± 2 °C/RH 75% ± 5%).

Materials and method: This study investigates the physicochemical and microbiological stability of rifampicin formulated in X-temp® OSS. The rifampicin suspension was prepared at 25mg/ml and kept in two types of amber-coloured storage bottles. The bottles were stored in an open and close storage system at 5 ^oC (refrigeration) and 30 °C/75% RH (non-refrigerated) and the stability of the product was evaluated at specified time intervals.

Results: It was found that the content of rifampicin remained above 90% of the original concentration throughout the study as required by the standard references. Visual appearance, colour, odour and pH remained unchanged throughout the study period and the extemporaneous preparation was not susceptible to microbial contamination.

Conclusion: Results from this stability study confirmed that the X-temp® OSS is a suitable vehicle for the preparation of extemporaneous rifampicin liquid formulation.

References

Allen, L. V., Jr., & Erickson, M. A. (1998). Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids. American Journal of Health-System Pharmacy, 55(17), 1804-1809. doi:10.1093/ajhp/55.17.1804

ASEAN Traditional Medicines and Health Supplements Scientific Committee Meeting (ATSC). (2013). ASEAN Guideline on Stability Study of Drug Product.Retrieved from: https://www.npra.gov.my/images/Guidelines_Central/ASEAN_Common_Technical_Requirements_ACTR/ASEAN-Guideline-on-Stability-Study-of-Drug-Produc-2013-2820th-ACCSQ-PPWG29.pdf

Baniasadi, S., Shahsavari, N., Namdar, R., & Kobarfard, F. (2015). Stability assessment of isoniazid and rifampicin liquid dosage forms in a national referral center for tuberculosis. International Journal of Pharma Science and Research, 6(4), 706-709. Retrieved from http://www.ijpsr.info/docs/IJPSR15-06-04-010.pdf

Cober, M. P., Johnson, C. E., Lee, J., & Currie, K. (2010). Stability of extemporaneously prepared rifaximin oral suspensions. American Journal of Health-System Pharmacy, 67(4), 287-289. doi:10.2146/ajhp090206

Dhanapal, C. K., Manavalan, R., Chandar, N., & Chenthilnathan, A. (2012). Formulation development of pediatric rifampicin oral suspension. Der Pharmacia Lettre, 4(3), 845-853.Council of Europe. (2001). European Pharmacopoeia. Strasbourg: Council of Europe.

Glass, B., & Haywood, A. (2006). Stability considerations in liquid dosage forms extemporaneously prepared from commercially available product. Journal of Pharmacy & Pharmaceutical Sciences, 9(3), 398-426.

Haslam, J. L., Egodage, K. L., Chen, Y., Rajewski, R. A., & Stella, V. (1999). Stability of rifabutin in two extemporaneously compounded oral liquids. American Journal of Health-System Pharmacy, 56(4), 333-336. doi:10.1093/ajhp/56.4.333

Jackson, M., & Lowey, A. (2010). Handbook of Extemporaneous Preparation. London: Pharmaceutical Press.

Jindal, K., Chaudhary, R. S., K, S., Gangwal, S., & Khanna, S. (1995). Effect of buffers and pH on Rifampicin stability. Die Pharmazeutische Industrie, 57, 420-422.

Jin, Q. & Kirk, M.F. (2018). pH as a primary control in environmental microbiology: 1. Thermodynamic perspective. Frontiers in Environmental Science, 6(21). doi: 10.3389/fenvs.2018.00021

Krukenberg, C. C., Mischler, P. G., Massad, E. N., Moore, L. A., & Chandler, A. D. (1986). Stability of 1% rifampin suspensions prepared in five syrups. American Journal of Hospital Pharmacy, 43(9), 2225-2228.

Marques-Marinho, F. D., & Vianna-Soares, C. D. (2013). Cellulose and Its Derivatives Use in the Pharmaceutical Compounding Practice. In T. Ven & L. Godbout (Eds.), Cellulose –Medical, Pharmaceutical and Electronic Applications (pp. 141-162). doi: 10.5772/56637

Nahata, M. C., Morosco, R. S., & Hipple, T. F. (1994). Effect of preparation method and storage on rifampin concentration in suspensions. Annals of Pharmacotherapy, 28(2), 182-185. doi:10.1177/106002809402800204

Osol, A.,& Hoover., J. E. (1975). Remington's Pharmaceutical Sciences(Vol. 65, 15thed). Easton,Pennsylvania: Mack Publishing Co.

Quick, J. D., Hogerzeil, H. V., Rankin, J. R., Graham, M. N., Laing, R., Garnett, A., & O'Connor, R. W. (1997). Managing drug supply: the selection, procurement, distribution, and use of pharmaceuticals. In J. D. Quick (Ed.), Management Sciences for Health in collaboration with the World Health Organization(2nded., p. 816). West Hartford, Connecticut: Kumarian Press.

Tilinca, M., Hancu, G., Mircia, E., Iriminescu, D., Rusu, A., Vlad, R.A., & Barabas, E. (2017). Simultaneous determination of isoniazid and rifampicin by UV spectrophotometry. Farmacia, 65(2), 219-224.

Rifampicin suspension. (2011). In United States Pharmacopeial Convention Committee of Revision (Ed.), United States Pharmacopeia -National Formulary(35thed., p. 1426). United States Pharmacopeial Convention.

Xue, D., & Sethi, R. (2012). Viscoelastic gels of guar and xanthan gum mixtures provide long-term stabilization of iron micro-and nanoparticles. Journal of Nanoparticle Research, 14. doi:10.1007/S11051-012-1239-0

Yalkowsky, Samuel H, & He., Y. (2003). Handbook of Aquoues Solubility Data.Boca Raton, Florida: Journal of American Chemical Society.